INO · Inovio Pharmaceuticals, Inc.

Summary

Inovio Pharmaceuticals, Inc. furnished Item 2.02 results of operations and Exhibit 99.1 Press Release dated March 12, 2026, via Form 8-K filed on 2026-03-12. The disclosure is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934.

Key takeaways

• Form 8-K filed on 2026-03-12
• Item 2.02 Results of Operations furnished
• Exhibit 99.1 Press Release dated March 12, 2026 filed herewith
• Item 9.01 Financial Statements and Exhibits disclosed
• Exhibit 104 Cover Page Interactive Data File included